| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6170204 | The Breast | 2013 | 10 Pages |
Abstract
In the last decade, the development of Hsp90 inhibitors has moved forward rapidly; however, no phase III trials have been conducted and none agent has been approved for use in the clinical practice.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Flora Zagouri, Theodoros N. Sergentanis, Dimosthenis Chrysikos, Christos A. Papadimitriou, Meletios-Athanassios Dimopoulos, Theodora Psaltopoulou,